Literature DB >> 8225448

A case control study of selenium in cancer.

K Krishnaswamy1, M P Prasad, T P Krishna, S Pasricha.   

Abstract

As selenium has been shown to be a risk modifier of cancer at several sites in a case-control approach, selenium nutriture was studied in oral and oesophageal cancer patients. The mean selenium level in oral cancer patients was 102.6 ng/ml and in oesophageal cancer 103.3 ng/ml, while in the matched controls it was 117.5 and 116.2 ng/ml respectively. Relative risk estimates were 3.16 (P < 0.02) and 16.0 (P < 0.01) in oral and oesophageal cancer patients respectively. The risk appears to increase with selenium levels lower than 115 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225448

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  5 in total

1.  Correlation of serum retinol and its relation with lipid prolile in Indian cancer patients.

Authors:  Rama Devi Mittal; Balraj Mittal
Journal:  Indian J Clin Biochem       Date:  2004-01

2.  Heavy and trace metals in carcinoma of the gallbladder.

Authors:  Somprakas Basu; Manish K Singh; Tej B Singh; Satyanam K Bhartiya; Sureshwar P Singh; Vijay K Shukla
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

3.  Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.

Authors:  Yumie Takata; Alan R Kristal; Regina M Santella; Irena B King; David J Duggan; Johanna W Lampe; Margaret P Rayman; Patricia L Blount; Brian J Reid; Thomas L Vaughan; Ulrike Peters
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

4.  Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial.

Authors:  Sunali S Khanna; Freny R Karjodkar
Journal:  Head Face Med       Date:  2006-10-16       Impact factor: 2.151

5.  Assessment of Serum Selenium and Ceruloplasmin in Potentially Malignant Disorders and Oral Cancer.

Authors:  Mathew O Mampilly; Nidhi Ravindran; Mohamed Shajith Parambil; Kumar Nilesh; Parvathi Jayagopalan; Debjit Dhamali
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.